Goldman Sachs Sees 21% Upside in Baxter (BAX) and Adds Stock to Conviction Buy List
Tweet Send to a Friend
Goldman Sachs upgraded Baxter International (NYSE: BAX) from Buy to Conviction Buy with a price target of $55, implying upside ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
